Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Takeo Hayashi
Non-Invasive Fibrosis Assessment Predicts Sustained Virological Response to Telaprevir With Pegylated Interferon and Ribavirin for Chronic Hepatitis C
Antiviral Therapy
Infectious Diseases
Pharmacology
A Case of Toxocariasis Suspected of Having Infiltrated Directly From the Liver to the Lung Through the Diaphragm
Internal Medicine
Internal Medicine
Medicine
Related publications
A Case of Chronic Hepatitis C, Genotype 3b Relapsed After Interferon Monotherapy, Treated With Pegylated Interferon Plus Ribavirin and Achieved Sustained Virological Response
Acta Hepatologica Japonica
Hepatology
Interferon-Ë Rs12979860CC Genotype Predicts Sustained Virological Response to Therapy in Patients With Chronic Hepatitis C Genotype 4 but Enhances Hepatic Fibrosis
Medical Journal of Viral Hepatitis
Sustained Virologic Response and IL28B Single-Nucleotide Polymorphisms in Patients With Chronic Hepatitis C Treated With Pegylated Interferon Alfa and Ribavirin.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction
Acta Hepatologica Japonica
Hepatology
Depressive Episode Incidence in Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin
Arquivos de Gastroenterologia
Gastroenterology
Hepatitis C Virus Core Protein Substitutions Affect the Response to Pegylated-Interferon and Ribavirin Therapy
BMC Genomics
Biotechnology
Genetics
Sudden-Onset Sarcoidosis With Severe Dyspnea Developing During Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C
Turkish Journal of Gastroenterology
Gastroenterology
Cognitive Function Does Not Worsen During Pegylated Interferon and Ribavirin Retreatment of Chronic Hepatitis C
Hepatology
Medicine
Hepatology
Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment With Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental